Income Statement
KIORA PHARMACEUTICALS INC
KPRX
Performance Overview
Click any row in the table to add it to this chart
in millions USD
| Metric | Dec 31, 2025 2025 FY | Dec 31, 2024 2024 FY | Dec 31, 2023 2023 FY | Dec 31, 2022 2022 FY | Dec 31, 2021 2021 FY | Dec 31, 2020 2020 FY | Dec 31, 2019 2019 FY | Dec 31, 2018 2018 FY | Dec 31, 2017 2017 FY | Dec 31, 2016 2016 FY | Dec 31, 2015 2015 FY |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Revenue
|
0.00 | 16.02 | - | - | 0.00 | 0.01 | 2.69 | 1.65 | 0.41 | 0.67 | - |
|
Cost of Revenue
|
- | - | - | - | - | - | - | - | - | - | - |
|
Gross Profit
|
- | 16.02 | - | - | - | 0.01 | 2.69 | 1.65 | 0.41 | 0.67 | - |
|
Operating Expenses
|
12.83 | 11.51 | 12.59 | 12.31 | 16.94 | 8.22 | 9.80 | 12.50 | 14.97 | 14.02 | 6.68 |
|
Research & Development
|
10.78 | 7.84 | 4.03 | 3.45 | 5.35 | 3.57 | 5.39 | 8.06 | 10.33 | 8.42 | 2.72 |
|
Selling, General & Administrative
|
5.75 | 5.54 | 4.66 | 8.28 | 5.32 | 4.66 | 4.41 | 4.44 | 4.64 | 5.59 | 3.96 |
|
Other Operating Expenses
|
- | - | - | - | - | - | - | - | - | - | - |
|
Operating Income
|
-12.83 | 4.51 | -12.59 | -12.31 | -16.94 | -8.21 | -7.11 | -10.84 | -14.56 | -13.35 | -6.68 |
|
Non-Operating Income
|
0.71 | 1.15 | 0.16 | -1.39 | 0.24 | 0.13 | 0.11 | 0.12 | 0.00 | 0.00 | -1.71 |
|
Interest Income
|
0.89 | 1.25 | 0.17 | 0.06 | 0.00 | 0.02 | 0.11 | 0.12 | 0.00 | 0.00 | 0.00 |
|
Interest Expense
|
- | - | 0.01 | 0.01 | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 1.93 |
|
Other Non-Op Income / Expense
|
-0.16 | 0.03 | 0.03 | - | - | - | - | - | - | 0.00 | 0.00 |
|
Income Before Tax
|
-12.12 | 5.66 | -12.42 | -13.70 | -16.70 | 8.08 | 7.00 | 10.73 | -14.56 | -13.34 | -8.39 |
|
Income Tax Expense
|
-1.28 | 2.07 | 0.09 | -0.11 | -0.30 | 0.01 | 0.10 | 0.09 | -1.34 | - | - |
|
Non-Controlling Interest
|
- | - | - | - | - | - | - | - | 0.00 | 0.00 | 0.01 |
|
Net Income
|
-10.84 | 3.59 | -12.51 | -13.58 | -16.39 | -8.09 | -7.10 | -10.81 | -13.22 | 0.51 | -8.39 |
Supplemental
Per share data, derived & other items — not part of the income statement
in millions USD unless noted
| Metric | Dec 31, 2025 2025 FY | Dec 31, 2024 2024 FY | Dec 31, 2023 2023 FY | Dec 31, 2022 2022 FY | Dec 31, 2021 2021 FY | Dec 31, 2020 2020 FY | Dec 31, 2019 2019 FY | Dec 31, 2018 2018 FY | Dec 31, 2017 2017 FY | Dec 31, 2016 2016 FY | Dec 31, 2015 2015 FY |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Depreciation & Amortization
|
- | - | - | - | - | - | - | - | - | - | - |
|
EBITDA
|
-12.81 | 4.53 | -12.54 | -12.27 | -16.90 | -8.18 | -7.06 | -10.81 | -14.54 | -13.34 | -6.68 |
|
Earnings Per Share (Basic)
|
-2.60 | 0.93 | -2.69 | -18.55 | -1.77 | - | - | - | - | - | - |
|
Diluted EPS
|
-2.64 | 0.87 | -2.69 | -18.55 | -1.77 | - | - | - | - | - | - |
|
Weighted Average Shares
|
4.17 | 3.87 | 4.84 | 0.73 | 9.24 | - | - | - | - | - | - |
|
Diluted Weighted Avg Shares
|
4.10 | 4.13 | 4.84 | 0.73 | 9.24 | - | - | - | - | - | - |
|
Comprehensive Income
|
- | - | - | - | - | - | - | - | - | -13.34 | -8.27 |